Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Net per vial: 10 mg (filled to approximately 104% of label)
Treatment typically begins with 0.25 mg once weekly for 4 weeks as an initiation dose only (not for glycaemic control)
They are safe, non-invasive, and provide a low-risk option for providers expanding weight loss and body sculpting services
This drug helps with diabetes and weight loss
Tirzepatide Semaglutide (Ozempic/Wegovy) activates GLP-1 receptors, which: Slows stomach emptying Reduces appetite Improves insulin sensitivity Typically results in 15-20% weight loss over a year Tirzepatide (Mounjaro/Zepbound) activates both GLP-1 and GIP receptors, which: Provides all semaglutide benefits May have stronger effects on glucose metabolism Often results in 20-25% weight loss over a year Sometimes has fewer gastrointestinal side effects Your optimal choice depends on your specific PCOS presentation
once your weight stabilizes or you stop taking the medication, the hair grows back
